Merck KGaA of Darmstadt, Germany, is looking at strategic options for the potential sale of its Consumer Health business. “We have continued to transform Merck KGaA, Darmstadt, Germany, over the last years into a leading science and technology company. Thereby we regularly review our portfolio in the context of our innovation driven strategy. Healthcare largely focuses on its Biopharma pipeline,” said Stefan Oschmann, chairman of the executive board and chief executive officer of Merck KGaA, ...